Literature DB >> 28820326

Heavy metal in cancer: The cell cycle jams with arsenic.

Alison K Barrett1, Seth M Rubin1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28820326      PMCID： PMC5602287          DOI： 10.1080/15384101.2017.1360653

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  6 in total

Review 1.  Sibling rivalry in the E2F family.

Authors:  Jeffrey M Trimarchi; Jacqueline A Lees
Journal:  Nat Rev Mol Cell Biol       Date:  2002-01       Impact factor: 94.444

Review 2.  PP1 and PP2A phosphatases--cooperating partners in modulating retinoblastoma protein activation.

Authors:  Victoria Kolupaeva; Veerle Janssens
Journal:  FEBS J       Date:  2012-02-29       Impact factor: 5.542

3.  Arsenic as an endocrine disruptor: effects of arsenic on estrogen receptor-mediated gene expression in vivo and in cell culture.

Authors:  Jennifer C Davey; Jack E Bodwell; Julie A Gosse; Joshua W Hamilton
Journal:  Toxicol Sci       Date:  2007-02-05       Impact factor: 4.849

Review 4.  Molecular mechanisms underlying RB protein function.

Authors:  Frederick A Dick; Seth M Rubin
Journal:  Nat Rev Mol Cell Biol       Date:  2013-04-18       Impact factor: 94.444

5.  Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide.

Authors:  S L Soignet; P Maslak; Z G Wang; S Jhanwar; E Calleja; L J Dardashti; D Corso; A DeBlasio; J Gabrilove; D A Scheinberg; P P Pandolfi; R P Warrell
Journal:  N Engl J Med       Date:  1998-11-05       Impact factor: 91.245

6.  Inhibition of E2F1 activity and cell cycle progression by arsenic via retinoblastoma protein.

Authors:  Lynn A Sheldon
Journal:  Cell Cycle       Date:  2017-09-28       Impact factor: 4.534
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.